Cambridge, Massachusetts
May 20–21, 2014
Presentations
Janet Woodcock, Head of CDER at the FDA
Keynote address (View slides)
White Papers
Achieving Continuous Manufacturing (White paper)
Clive Badman and Bernhardt L. Trout
Technologies and Approaches for Synthesis Work-Up and Isolation of Drug Substance (Abstract; View slides)
Ian R. Baxendale, Richard D. Braatz, Benjamin K. Hodnett, Klavs F. Jensen, Martin D. Johnson, Paul Sharratt, Jon-Paul Sherlock, and Alastair J. Florence
Achieving Continuous Manufacturing for Final Dosage Formation: Challenges and How to Meet Them (Abstract; View slides)
Stephen Byrn, Maricio Futran, Hayden Thomas, Eric Jayjock, Nicola Maron, Robert F. Meyer, Allan S. Myerson, Michael P. Thien, and Bernhardt L. Trout
Regulatory and Quality Considerations for Continuous Manufacturing (Abstract; View slides)
Gretchen Allison, Yanxi Tan Cain, Charles Cooney, Tom Garcia, Tara Gooen Bizjak, Oyvind Holte, Nirdosh Jagota, Bekki Komas, Evdokia Korakianiti, Dora Kourti, Rapti Madurawe, Elaine Morefield, Frank Montgomery, Moheb Nasr, William Randolph, Jean-Louis Robert, Dave Rudd, and Diane Zezza
Continuous Bioprocessing (Abstract; View slides)
Konstantin B. Konstantinov and Charles L. Cooney
Equipment and Analytical Companies Meeting Continuous Challenges (Abstract; View slides)
Trevor Page, Henry Dubina, Gabriele Fillipi, Roland Guidat, Saroj Patnaik, Peter Poechlauer, Phil Shering, Martin Guinn, Peter Mcdonnell, and Craig Johnston
Control Systems Engineering in Continuous Pharmaceutical Manufacturing (Abstract; View slides)
Allan S. Myerson, Markus Krumme, Moheb Nasr, Hayden Thomas, and Richard D. Braatz
Future Supply Chains Enabled by Continuous Processing – Opportunities and Challenges (Abstract; View slides)
Jagjit Singh Srai, Clive Badman, Markus Krumme, Mauricio Futran, and Craig Johnston
How Development and Manufacturing Will Need to Be Structured – Heads of Development/Manufacturing (Abstract; View slides)
Kevin Nepveux, Jon-Paul Sherlock, Mauricio Futran, Michael Thien, and Markus Krumme